The UK government has further added 210 million euros to accelerate the support and to find a coronavirus vaccine. So this will make the total fund as 544 million euros. This makes the government of the UK the biggest contributor to the Coalition for Epidemic Preparedness Innovations (CEPI).
CEPI is the international coalition to find a COVID-19 vaccine. These decisions informed in a virtual summit of G20 leaders.
Governments around the world must step up to help us defeat #coronavirus.
I’ve announced a further £210m of aid funding for vaccine research following today's G20 call, meaning the UK is going above and beyond in the search for a vaccine.
— Boris Johnson (@BorisJohnson) March 26, 2020
The British Prime Minister’s Announcement Regarding the Funds
Borris Johnson, the British Prime Minister, who has recently tested positive for coronavirus has announced about this additional fund.
“My call to every G20 country and to governments around the world is to step up and help us defeat this virus. “
“While our brilliant doctors and nurses fight coronavirus at home, this record British funding will help to find a vaccine for the entire world. UK medics and researchers are at the forefront of this pioneering work,” he announces.
The Plans on Coronavirus Vaccine Fund
This 544 million euros is sufficient to treat our entire world. This fund is for the treatment and discovery of a vaccine. The UK government allot 210 million euros to develop a vaccine against COVID-19. In this allotted amount they have already contributed 40 million euros to CEPI organization. Therefore, this will help scientists and researchers to work in the development of the COVID-19 vaccine.
We all know that we can’t keep on focusing on Coronavirus vaccines all the time. We should also care about patients who are helpless. Even though we can’t able to cure them we should try to make them feel better. It’s not that all the people belong to the same social status. Some can afford high-quality medications while some cannot.
Therefore to provide good medications throughout our globe, they allot another 40 million euros to the treatment of COVID-19 patients. This will support the Therapeutic Accelerator, a fund for the rapid development of antiretrovirals or immunotherapies against COVID-19.
In some countries due to a lack of technology and medical devices, people are not able to find the COVID-19 infected person. So to stop this, the UK government allot another 23 million euros to easily manufactured testing devices. This will build rapid testing technology like the new prototype test. This is developed by the Mologic lab in Bedford, which is currently funded by the UK.